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ABSTRACT
Objective: The purpose of this study was to verify the presence of endothelial dysfunction and ini-
tial structural atherosclerotic changes in children with Type 1 diabetes mellitus (T1DM). Subjects 
and methods: The study population comprised 31 diabetic children aged 6 to 12 years, divided into 
two subgroups according to the duration of the T1DM diagnosis: subgroup 1, with less than 5 years 
elapsed since diagnosis, and subgroup 2, with more than 5 years elapsed since diagnosis. The control 
group comprised 58 age-matched healthy children. Ultrasonographic techniques were used to mea-
sure the flow-mediated dilatation (FMD) of the brachial artery and the intima-media thickness (IMT) of 
the carotid arteries. Results: Children with T1DM with longer disease duration showed significantly 
decreased mean values of FMD compared with those in the control group. No significant differences 
between the groups were found in relation to IMT. The FMD percentage presented a moderate nega-
tive correlation with glycated hemoglobin (HbA1c) and fasting glucose levels. Conclusion: Our find-
ings suggest that endothelial dysfunction may be already present in children with 5 years or more 
elapsed since diagnosis, even in the absence of atherosclerotic structural changes. The decreased 
vasodilation response correlated with hyperglycemia. Arch Endocrinol Metab. 2017;61(5):476-83
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T ype 1 diabetes mellitus (T1DM) is currently one of the most common chronic diseases in childhood, 
displaying a high frequency of complications involving 
microvascular and macrovascular abnormalities (1).
Metabolic abnormalities characterizing T1DM, such 
as hyperglycemia and increased circulating free fatty 
acids, trigger molecular mechanisms that contribute 
to the development of endothelial dysfunction. These 
mechanisms include a decreased bioavailability of 
nitric oxide, increased oxidative stress, disturbances 
in intracellular signal transduction, and activation of 
advanced glycation end products (AGEs) (2).
Endothelial dysfunction, thought to be an early event 
in the structural changes of the atherosclerotic process, 
is characterized by abnormalities in the regulation of the 
lumen of the vessels, resulting in a blunted vasodilatory 
response (3). This vascular endothelial impairment results 
in increased production of inflammatory cytokines and 
augmented expression of cellular adhesion molecules 
and several other biologically active substances that 
contribute to the induction of a proinflammatory and 
prothrombotic state (4). These mechanisms represent 
an important step in the development of the initial 
atherosclerotic changes and subsequent complications 
in patients with T1DM (5).
Although the macrovascular complications 
of T1DM do not usually disclose major clinical 
manifestations during childhood and adolescence, 
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resolution ultrasound equipment allows an early 
diagnosis of endothelial dysfunction through the 
study of flow-mediated dilation (FMD) of the brachial 
artery. Additionally, the measurement of the carotid 
intima-media thickness (IMT) allows the detection of 
initial atherosclerotic alterations (6). FMD is defined 
as a reactive vasodilatation of the brachial artery after 
hyperemic stimulation (7) and when decreased, has a 
predictive value for future cardiovascular disease (8). 
Similarly, increased carotid artery width measured 
with the IMT technique is a risk factor for future 
atherosclerosis or suggestive of an already established 
atherosclerosis and an atherosclerotic process affecting 
peripheral, coronary, and femoral arteries. IMT is 
considered a strong predictor of vascular disease in 
high-risk individuals, such as those with T1DM (9).
The evaluation of children with T1DM using 
the FMD technique and IMT measurement at an 
early preclinical stage of the disease could allow the 
implementation of strategies to prevent or at least 
reduce the cardiovascular morbidity and mortality in 
diabetic children. Consequently, the aim of our study 
was to evaluate children with T1DM without evidence 
of microvascular or macrovascular complications for the 
presence of endothelial dysfunction and early vascular 




The study group comprised 31 children aged 6 to 12 
years (mean age 8.36 ± 1.81 years) divided into two 
subgroups according to the time elapsed since the 
diagnosis of T1DM: subgroup 1, diagnosed within 
the previous 5 years (mean time from diagnosis 2.73 
± 1.11 years) and subgroup 2, diagnosed more than 5 
years before the study (mean time from diagnosis 6.11 
± 1.28 years). 
A total of 58 healthy children aged 6-12 years 
(mean 6.9 ± 1.77 years) comprised the control group. 
The diabetic children were recruited among patients 
attending the Pediatric Endocrinology Outpatient Clinic 
at the Brasilia University Hospital and the Pediatric 
Clinic of the Brasilia Children’s Hospital. Children in 
the control group were selected among dependents 
of the hospital’s employees. In order to minimize the 
influence of other factors on the endothelial function 
excluding those due to T1DM, we followed the criteria 
of inclusion and exclusion described in Table 1.
The study was conducted according to the 
Declaration of Helsinki, and the Ethics Committee of 
the University of Brasilia School of Medicine approved 
the study protocol. Written informed consent was 
obtained from the legal guardians of the children. 
Study design and sample size calculation
The sample size was calculated with the software Epi 
Info, version 3.5.3. A minimum sample size of 66 
children was obtained, considering a maximum error 
of 5% and a 95% confidence interval. The final sample 
comprised 31 patients with T1DM and 58 healthy 
controls, totaling 89 children. 
Table 1. Inclusion and exclusion criteria 
Inclusion criteria for the T1DM children group 
Absence of microvascular complications*
Inclusion criteria for the control group
Normal weight and height for age**  
Fasting glucose < 100 mg/dL
HbA1c ≤ 5.6%
hsCRP < 0.3 mg/dL
Exclusion criteria for both groups
Onset of puberty***
Arterial hypertension****
Total cholesterol ≥ 200 mg/dL
HDL cholesterol < 45 mg/dL
LDL cholesterol ≥ 130 mg/dL
VLDL cholesterol ≥ 41mg/dL
Triglycerides ≥ 100 mg/dL
Hemoglobin < 11 g/dL
Hematocrit < 33%
Family history of primary dyslipidemia
Family history of premature death from CVD or stroke
Presence of acute infectious conditions 
Chronic diseases, lasting 3 months or more, excluding T1DM
Continuous use of drugs, except insulin
T1DM: type 1 diabetes mellitus; HbA1c: glycated hemoglobin; hsCRP: high sensitive C-reactive 
protein; CVD: cardiovascular disease.
*All children underwent a detailed physical examination by a pediatric endocrinologist (that 
included assessment of blood pressure and skin sensitivity), specific serum and urinary 
biochemical tests (including a complete renal function and microalbuminuria), and complete 
ophthalmic evaluation. ** According to CDC growth charts (Kuczmarski and cols., 2002 [30]) 
adapted for Brazilian children (Silva and cols., 2010 [31]). *** Children not presenting Tanner 
stage M1P1 (females) or G1P1 (males) were excluded. **** Blood pressure was measured with 
suitable cuffs and classified according to systolic and diastolic curves, specific for each age, 
gender, and height, in agreement with the curves of the Second Task Force on Blood Pressure 
Control in Children (1996). High blood pressure was diagnosed when the percentiles of systolic 
and/or diastolic readings were above the 95th percentile for age and sex, on at least three 
occasions. If the readings were between the 90th and 95th percentiles, the blood pressure was 
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Ultrasound studies
The ultrasonographic studies were performed with 
ultrasound equipment model ACUSON X 300 
(Siemens HG, Munich, Germany), equipped with a 
vascular software for two-dimensional (2D) and color 
images, color and spectral Doppler, internal monitor 
for echocardiography, and a high-frequency (8.9 MHz) 
vascular transducer (VF13-5). All images were obtained 
and evaluated by the same examiner and processed 
manually with an ultrasonic compass. Each child 
underwent both ultrasound techniques sequentially, 
always in the afternoon, in dimmed light, and at room 
temperature (23°C). 
Brachial artery FMD
Neither the consumption of high-fat foods, vitamin C, 
and stimulants beverages (e.g. caffeine), nor intense 
physical activity during the previous 24 hours 
was allowed before the FMD evaluation. All tests 
were preceded by blood pressure measurement 
after 10 minutes of rest, using a pneumatic 
sphygmomanometer with a cuff appropriate for the 
child’s upper limb size. Electrodes were applied for 
continuous electrocardiographic monitoring. In 
accordance with protocols suggested by Corretti 
and cols. and Barac and cols. (10,11), the children 
were placed comfortably in a supine position with 
the sphygmomanometer cuff placed on their left 
forearm over the brachial artery, 5 to 15 cm above 
the antecubital fossa. Initially, a baseline image of 
the left brachial artery in a longitudinal plane was 
obtained, and its quality was further optimized 
in a 2D mode. The image was subsequently 
expanded and recorded for 1 minute to allow later 
measurement of the larger artery diameter at rest (at 
the end of diastole, which coincides with the R wave 
of the QRS complex of the continuous ECG). The 
cuff was then inflated 50 mmHg above the systolic 
pressure (10,11) during 4 minutes (8). New images 
of the brachial artery were obtained 1, 3, 5, and 9 
minutes after cuff deflation. After that, new images 
were obtained allowing measurement of the maximal 
diameter and the flow of the brachial artery. The 
arterial lumen diameter was defined as the distance 
between the intima of the far and near vessel walls. 
The dilatation was calculated by subtracting the 
lumen diameter at baseline from the maximal lumen 
diameter after ischemia and dividing the result by 
the lumen diameter at baseline (12). Results were 
expressed as a percentage FMD (%).
Carotid artery IMT
All measurements were performed according to 
the protocol described by Järvisalo and cols. and 
Bots and cols. (13,14). Images of the right and left 
common carotid arteries were obtained in 2D mode 
with the subjects in a supine position with their 
heads lateralized, and the transducer positioned on 
the contralateral vessel at an approximate angle of 
45°, about 1 to 2 cm proximal to the bifurcation of 
the carotid artery. The images of each artery were 
subsequently magnified to allow the measurement 
of the IMT of the posterior wall, at the end of the 
diastole (at the onset of the QRS complex). The IMT 
was defined as the distance between the lumen-intima 
and media-adventitia ultrasound interfaces of the 
carotid artery measured in mm (12).
Statistical analysis
The results are shown as mean ± standard deviation. 
Statistical analyses were performed using the software 
GraphPad Prism, version 5.0 (GraphPad Software, San 
Diego, California, USA). Student’s t test or permutation 
tests (Kruskal-Wallis) were applied for comparisons with 
the control group. One-way ANOVA was used when 
applicable, and Dunnett’s post-test was used when 
diabetic children were compared with the children in 
the control group. To quantify the association between 
two variables, Pearson’s correlation coefficient was 
used. The data were considered statistically significant 
when p ≤ 0.05.
RESULTS
Characteristics of the groups
The demographic and laboratory profile of the 
diabetic and control groups are shown in Table 2. 
Both groups were similar regarding gender and age. 
The laboratory profiles showed statistical differences 
in levels of triglycerides and VLDL cholesterol 
between the groups, although the results were still 
within the normal reference values. As expected, the 
levels of glycated hemoglobin (HbA1c) and fasting 
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In order to establish if the disease duration 
influenced the results above, the diabetic group 
was further divided into two subgroups. The first 
subgroup comprised 22 children diagnosed with 
diabetes less than 5 years before the study (T1DM 
< 5, 14 males and 8 females, mean age 8.64 ± 1.79 
years). The second group comprised 9 children 
diagnosed with diabetes more than 5 years before 
the study (T1DM ≥ 5, 5 males and 4 females, mean 
age 10.1 ± 1.27 years). When compared with the 
control group, both subgroups (T1DM < 5 and 
T1DM ≥ 5) continued to show significant p values 
for HbA1c (8.83 ± 1.56%, p = 0.015 and 9.57 ± 
1.79%, p = 0.018, respectively) and fasting glucose 
(194.14 ± 103.94 mg/dL, p = 0.0002 and 170.11 
± 89.11 mg/dL, p = 0.002, respectively) when 
compared with the control group.
Ultrasound studies
Results obtained with the brachial artery FMD 
technique are shown in Table 3.
No significant differences were found in the 
percentage increase in the arterial FMD (%) between 
the control group (11.45 ± 2.86%) and subgroup 
T1DM < 5 (10.21 ± 2.70%, p = 0.078), but a significant 
difference was observed when the control group was 
compared with the subgroup T1DM ≥ 5 (7.04 ± 
1.38%, p = 0.0001). The timing of the maximal dilation 
after stimulation did not change with the division into 
subgroups. There was no significant difference in the 
percentage of increase in FMD between genders (data 
not shown), both in the control group and diabetics 
subgroups in the four repeated measurements 
performed after post-occlusive reactive hyperemia. 
Similarly, no significant differences between groups 
were observed in the analysis of parameters related 
to the brachial artery, including systolic peak (SP), 
pulsatility index (PI), resistivity index (RI), maximum 
acceleration time (AT max), end diastolic speed (ED), 
and the ratio peak systolic velocity/peak diastolic 
velocity (S/D). The results from the measurements of 
the carotid arteries obtained with the IMT technique 
are shown in Table 4.





Controls (n = 58) T1DM (n = 31) T1DM < 5 (n = 22) T1DM ≥ 5
Female 24 (41.4%) 12 (38.7%) 8 (36.4%) 4 (44.4%) 0.8068




Controls T1DM total T1DM < 5 T1DM ≥ 5
Hemoglobin (mg/dL) 13.65 (±0.84) 13.70 (±0.90) 13.54 (±0.81) 14.10 (±1.03) 0.8060*
Hematocrit (%) 40.26 (±2.97) 40.30 (±2.32) 39.87 (±2.25) 41.36 (±2.26) 0.9402*
Glycated hemoglobin (%) 5.30 (±0.27) 9.04 (±1.64) 8.83 (±1.56) 9.57 (±1.79) < 0.0001*
0.015**
0.018***
Total cholesterol (mg/dL) 166.95 (±22.14) 165.42 (±16.92) 165.27 (±17.53) 165.78 (±16.33) 0.7172*
Triglycerides (mg/dL) 63.80 (±16.7) 60.23 (±20.26) 57.95 (±18.35) 65.78 (±24.62) 0.0198*
HDL cholesterol (mg/dL) 51.47 (±9.70) 53.87 (±8.66) 51.59 (±6.73) 59.44 (±10.64) 0.2357*
LDL cholesterol (mg/dL) 101.95 (±18.06) 99.84 (±17.09) 102.59 (±16.71) 93.11 (±17.05) 0.5884*
VLDL cholesterol (mg/dL) 12.60 (±3.33) 14.40 (±4.84) 11.59 (±3.69) 13.22 (±4.79) 0.0179*
Fasting glucose (mg/dL) 84.40 (±9.03) 187.16 (±99.01) 194.14 (±103.94) 170.11 (±89.11) < 0.0001*
0.0002**
0.002***
*P values were obtained by comparing the mean (± standard deviation [SD]) values obtained in each group, applying Student’s t test. ** P values were obtained by comparing the mean (±SD) values 
obtained in the control group versus those in the T1DM < 5 subgroup. *** P values were obtained by comparing the mean (±SD) values obtained in the control group versus those in the T1DM ≥ 5 
subgroup applying Student’s t test, chi-square test, and Kruskal-Wallis test. All results are expressed as mean ± SD values.
Anthropometric data: percentiles (ranging from 50-85%) were normal for age and weight both in the diabetic and control groups. The mean body mass index (BMI) for the group of diabetic children 
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Correlation between the variables FMD (%) and 
HbA1c
Pearson’s linear correlation coefficient, which evaluates 
the correlation between two measurable variables, was 
applied to determine the presence of a relationship 
between the FMD (%) and serum levels of HbA1c 
(Figure 1), and FMD (%) and fasting glucose (Figure 2). 
The test revealed a moderately negative correlation 
between FMD (%) and HbA1c (r = -0.36, p = 0.0025) 
and between FMD (%) and fasting glucose (r = -0.36, p = 
0.0024) (Figure 2). As these correlations were negative, 
the coefficient suggested that the higher the level of 
HbA1c and fasting glucose, the lower the FMD (%), 
confirming our hypothesis.
DISCUSSION
Macrovascular and microvascular complications are 
the main causes of morbidity and mortality in patients 
with diabetes mellitus, and their main trigger may 
be represented by dysregulation of the modulatory 
function of the vascular endothelium (15). It is an 
accepted fact that T1DM predisposes to premature 
atherosclerotic artery disease and there is evidence 
that the endothelial function impairment precedes the 
establishment of this pathological process (16).
The endothelial cells actively adjust the vascular 
tonus and reactivity in physiological and pathological 
conditions in response to mechanical stimuli and 
neurohumoral mediators with the release of a variety 
of factors leading to vascular constriction or relaxation. 
Additionally, these cells synthesize substances with a 
regulatory function on inflammation and hemostasis 
(3). Since the action of these cells can affect one or more 
functions simultaneously or sequentially, a gold-standard 
test to evaluate the presence of endothelial dysfunction 
has not yet been established (3). However, the endothelial 
function has been generally evaluated by changes in 




Controls T1DM total T1DM < 5 T1DM ≥ 5
Mean brachial artery baseline diameter (mm) 2.59 (±0.13) 2.59 (±0.13) 2.58 (±0.13) 2.60 (±0.13) 0.887*
Max FMD (%) 11.45 (±2.86) 9.29 (±2.79) 10.21 (±2.70) 7.04 (±1.38) 0.0008*
0.078**
0.0001***
Max FMD time (min) 1 (±1.13) 1(±1.69) 1(±1.81) 1 (±1.41) 0.753*
T1DM: type 1 diabetes mellitus; FMD: flow-mediated dilation; max FMD (%): maximal FMD (%); max FMD time: time to the occurrence of the maximal FMD.
* P values were obtained by comparing the mean (± standard deviation [±SD]) values in the control group with those in the entire T1DM group, with the application of the Kruskal-Wallis test. 
** P values were obtained by comparing the mean (±SD) values in the control group with those in the T1DM < 5 subgroup. *** P values were obtained by comparing the mean (±SD) values in the 
control group with those in the T1DM ≥ 5 subgroup, with the application of the Kruskal-Wallis test. All results are expressed in mean (±SD) values.




Controls T1DM total T1DM < 5 T1DM ≥ 5
IMT LCA mean 0.55 (± 0.04) 0.56 (± 0.06) 0.55 (± 0.05) 0.57 (± 0.08) 0.762*
0.737**
0.208***




LCA and RCA (mm)
0.61 (± 0.06) 0.61 (± 0.05) 0.60 (± 0.04) 0.63 (± 0.07) 0.826*
0.628**
0.252***
IMT: intima-media thickness; LCA: left carotid artery; RCA: right carotid artery; Max: maximal. 
* P values correspond to the comparison of the mean (± standard deviation [SD]) values in the entire T1DM group versus those in the control group. ** P values correspond to the comparison of the 
mean (±SD) values in the T1DM < 5 subgroup and those in the control group. *** P values correspond to the comparison of the mean (±SD) values in the T1DM ≥ 5 subgroup with those in the 
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blood flow or measurement of blood vessel diameter 
in response to mechanical or chemical stimulation, 
measured invasively (by coronary catheterization) or 
noninvasively (by ultrasound technique) (3). The latter 
was the method used in our study.
flux of glucose through the polyol (sorbitol) pathway 
(1). Thus, the imbalance between the production of 
endothelium-derived factors impairs the vascular tonus 
and other physiological properties of the vascular 
endothelium (3), favoring vasoconstriction (18) and an 
inflammatory state (4), perpetuated by the long-lasting 
hyperglycemia (19). The results of Pearson’s correlation 
coefficients corroborate these claims in our population, 
suggesting a moderate association between decreased 
vasodilation and increased serum levels of HbA1c and 
fasting glucose (Figures 1 and 2, respectively).
On reviewing the FMD technique protocol, we 
found a disagreement among several authors regarding 
the degree of occlusion to be applied. Corretti and 
cols. (10) and Barac and cols. (11) advocate inflating 
the blood pressure cuff to ≥ 50 mmHg above the 
patient’s systolic pressure, while Shivalkar and cols. (8) 
recommend inflating the cuff to 100 mmHg above 
the systolic pressure. In our pediatric population, we 
chose to inflate the cuff to 50 mmHg above the systolic 
pressure, considering that there was a consensus in this 
regard between two of the authors and because this 
pressure was more comfortable for the children. 
Another controversial point was the duration 
of the occlusion. Corretti and cols. (10) favored an 
occlusion duration of 5 minutes since changes in the 
vessel diameter are similar after 5 or 10 minutes and 
an occlusion for 5 minutes is more easily tolerated. 
However, in our experience, this recommendation was 
difficult to be carried out in our children, who showed 
considerable intolerance toward remaining with the 
cuff inflated 50 mmHg above the systolic pressure 
throughout the 5 minutes. Based in a previous study 
(8) that applied an occlusion duration of 4 minutes to 
adult patients obtaining good results, and considering 
that our patients were aged 6 to 12 years, we adopted 
this 4-minute occlusion time. This duration was well 
tolerated by our children and did not affect the test 
since the increase in the brachial artery diameter after 
cuff release occurs within 30 seconds to 5 minutes, and 
these changes in diameter are similar after 5 and 10 
minutes (10).
The maximal dilatation response in our diabetic 
and control children was obtained 1 minute after the 
hyperemic stimulus (Table 3). Previous studies have 
suggested that the maximal increase in arterial diameter 
occurs approximately 60 seconds after cuff release 
(20-22). Our results are in accordance with those 
obtained by other authors, and the baseline brachial 
Figure 2. Pearson’s linear correlation scatter plot of the percentage of 
maximal flow-mediated dilation (FMD %) versus fasting glucose levels. 
Figure 1. Pearson’s linear correlation scatter plot of the percentage of 
maximal flow-mediated dilatation (FMD %) versus glycated hemoglobin 
(HbA1c) levels.
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Our results revealed significant differences in 
relation to fasting glucose and HbA1c levels between 
the diabetic patients’ groups (T1DM < 5 and T1DM 
≥ 5) and the control group (Table 2), reflecting a 
suboptimal glycemic control in diabetic patients 
independent of the time from diagnosis. A lasting 
hyperglycemic state can affect the endothelial function 
due to alteration of molecular regulatory mechanisms 
of the nitric oxide synthesis and/or degradation (4) 
and the onset of oxidative stress inducing a deleterious 
effect on the endothelial cells (17). This process 
involves four metabolic pathways, with activation 
of protein kinase C (PKC), the formation of AGEs, 
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artery diameter was similar in all our groups (Table 3), 
thus eliminating any bias related to the baseline artery 
size since arteries with larger diameters show lower 
percentages of maximal dilation and vice versa (7).
In spite of FMD abnormalities in the T1DM ≥ 5 
subgroup when compared with controls (Table 3), we 
could not find in our study IMT abnormalities in any 
of the diabetic subgroups (Table 4), which suggests 
the inexistence of atherosclerotic structural alterations 
that usually evolve after the advent of endothelial 
dysfunction.
Assessing our results and comparing our FMD and 
IMT findings with data reported in a previous study, we 
detected similar results in a group of diabetic children 
with a mean age of 14 years and a disease duration 
of 6 years. These children also failed to show vascular 
complications, although they presented impaired 
endothelial function assessed by FMD when compared 
with a control group (23). Similarly, a decreased FMD 
response was detected in a Finnish population with 
T1DM without microvascular complications, aged 7 
to 14 years and with a mean disease duration of 4.4 ± 
2.9 years. However, differently from our results, the 
subgroup with endothelial dysfunction in that study 
had significantly higher values  of carotid IMT than 
the subgroup without endothelial dysfunction and the 
control group; no statistically significant differences 
were observed in the brachial artery baseline diameter, 
disease duration or HbA1c levels among diabetic 
children with and without endothelial dysfunction 
(6). In another study, Singh and cols. (24) also found 
no differences in carotid artery IMT between diabetic 
patients and control individuals, although the FMD 
detected was significantly lower in the diabetic group. 
These authors concluded that although the endothelial 
dysfunction appears during the first decade of T1DM 
onset, increased carotid IMT only occurs after a more 
extended time.
In another, more recent study, Eltayeb and cols. 
(25) assessed the endothelial function and myocardial 
alterations in pediatric patients with T1DM aged 5 
to 16 years, without microvascular complications, 
and with a duration of 1-4 years from the initial 
diagnosis. These authors also reported a maximal FMD 
significantly lower and carotid IMT significantly higher 
in the diabetic group when compared with the control 
group. Similarly, a Turkish T1DM study conducted by 
Çiftel and cols. (27) in a group of children aged 7 to 16 
years with a disease duration of at least 5 years from the 
diagnosis and no microvascular diabetic complications 
or additional cardiovascular risk showed a lower FMD 
and higher carotid IMT when comparing diabetic 
subjects with controls.
A recent Italian longitudinal study by Bruzzi 
and cols. (28) demonstrated in a group of children 
and adolescents aged 5 to 18 years and with a mean 
time elapsed from diagnosis of 4 years, that after a 
mean follow-up of 3 years, the endothelial function 
deteriorates sharply and that the male gender is 
considered a negative predictor of impaired FMD 
over time. Additionally, these authors reported that 
the maintenance of blood glucose levels near the 
normal range apparently does not avert the evolution 
of diabetic vasculopathy, suggesting the influence of 
intrinsic (genetic) and extrinsic (nutritional factors, 
physical inactivity) factors in the establishment of the 
endothelial damage.
The endothelial vasomotor activity is generally 
higher in females than males. Various hypotheses 
have been proposed to explain this fact: smaller 
body surface area, lower body mass index, and lower 
baseline diameter of the brachial artery in females when 
compared with males. Additionally, in prepubertal and 
adult subjects, estrogen can improve the endothelial 
function (29). No gender difference was detected in the 
vasodilatation response both in the T1DM and in the 
control group, probably due to similar baseline brachial 
artery diameters and lack of hormonal influence, since 
all children in our study were in the prepubertal stage. 
This study is relevant for assessing the presence of 
endothelial dysfunction in T1DM children from an 
early age to the prepubertal stage, with a wide range 
of disease duration, and by noninvasive methods, 
further evidencing an association of diabetes with 
early structural atherosclerotic alterations. However, 
the study has some limitations. It does not clarify 
if the assessment of the endothelial function by the 
FMD technique and the laboratory determination of 
adhesion molecules and other inflammatory factors are 
clinically useful tools to stratify the cardiovascular risk in 
T1DM population groups or individual children. It also 
does not determine if an improvement in endothelial 
function would decrease the risk of development of 
future vascular atherosclerotic complications. 
In conclusion, our study suggests that endothelial 
dysfunction without structural changes suggestive of 
atherosclerosis may appear in diabetic children with a 
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children, a decreased vasodilation response correlates 
with a higher degree of hyperglycemia. 
As the decreased reactivity of the brachial artery 
seems to improve with the modification of risk factors 
and drug treatment to reduce the cardiovascular risk, 
the acknowledgement of the presence of endothelial 
dysfunction in diabetic children allows the adoption of 
preventive strategies to mitigate the consequences of 
T1DM in this population, contributing to the reduction 
of the morbidity and mortality of the disease in adulthood.
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